Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,318Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Naprod Life Sciences

02 4ABEX Pharmaceutica

03 3Accure Labs

04 1Adamed Pharma

05 9Apotex Inc

06 7F. Hoffmann-La Roche

07 2Flagship Biotech International Pvt. Ltd

08 1Globela Pharma

09 3Intas Pharmaceuticals

10 4Jodas Expoim Pvt. Ltd

11 3Laboratorio Eczane Pharma

12 1Murli Krishna Pharma

13 3Nobel Ilac Sanayii Ve Ticaret A.S.

14 1ORIFARM GROUP AS

15 3Pharmascience Inc.

16 1Pluviaendo

17 2Sakar Healthcare

18 9Sandoz B2B

19 2Sichuan Xieli Pharmaceutical

20 3Teva Pharmaceutical Industries

21 4UQUIFA

22 2United Biotech

23 3West-Coast Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Cancer Research
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Erlotinib

Brand Name :

Dosage Form : Tablets

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

02

arrow
Cancer Research
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Erlotinib

Brand Name :

Dosage Form : Tablets

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

03

arrow
Cancer Research
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Erlotinib

Brand Name :

Dosage Form : Granules

Dosage Strength : 33.33%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

04

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

05

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

06

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

07

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

08

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Erlotinib 100Mg 30 Joined' Oral Use

Dosage Strength : 30 cpr riv 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Erlotinib 150Mg 30 Joined' Oral Use

Dosage Strength : 30 cpr riv 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

11

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 150 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 25 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

14

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

15

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

16

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

17

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

18

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

19

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Ertinob

Dosage Form : Film Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

20

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Ertinob

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

21

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Ertinob

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

22

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 150 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

23

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

blank

24

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

blank

25

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Canada

blank

26

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : China

blank

27

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : China

blank

28

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

29

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

30

Cancer Research
Not Confirmed
arrow
arrow
Cancer Research
Not Confirmed

Erlotinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Europe

blank